Better forecasting.
We are an independent predictive analytics company - cited over 70,000 times
Offerings
Products
Respiratory Infectious Disease Forecasting - FRIDA™
FRIDA™ delivers accurate, real-time forecasts of infectious disease dynamics across key respiratory pathogens, including influenza, COVID-19 and RSV. Built on backtested epidemiological models, it gives teams clear short- and medium-term visibility into disease spread. AI-powered to simulate outcomes.
Learn more →
Infectious Disease Intel - OneID
One ID is the world’s leading, continuously updated, infectious disease intelligence platform - relied on by 9 out of 10 of the largest pharmaceutical providers within infectious diseases.
Learn more →
Biorisk Intel - OneID
Power pandemic-preparedness and response with continuous monitoring of global biological threats. Strengthen biosecurity planning with actionable, decision-ready intelligence.
Learn more →
Drug & Vaccine Demand Forecasting - Nexa
Nexa delivers forecasting and simulation for drug and vaccine demand—engineered for volatile, fast-moving markets. Run scenarios, stress-test assumptions and get always-on, data-driven visibility into peak and total sales.
Learn more →
Custom solutions
Highly Accurate - Second Opinion Forecasts
Access unbiased, data driven and always-on, second opinion commercial forecasts for the peak and total sales of your drug or vaccine.
Learn more →
Competitive Intelligence
Forward-looking competitive and medical intelligence that identifies pipeline threats, differentiation risk, and commercial opportunity.
Learn more →
Burden of Disease Modelling
Understand and predict current disease burden. Our granular models of cases, hospitalization and other disease burden metrics provide evidence and knowledge even where data is sparse.
Learn more →
What our users say
"In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists can analyse, model and provide strategic analysis for critical decision making."
Iskra Reic, Executive Vice-President
Astrazeneca
“A big thank you to the Airfinity team for the quality of the service you have delivered over the past few years. The INTREPID Antiviral Development Landscape has become a leading reference for governments, WHO, industry and philanthropies who are investing in antivirals thanks in great part to your service.”
Nina M. Hill, Ph.D.
INTREPID Alliance
See predictive analytics in action
Tap into Airfinity’s AI-powered forecasting and simulation solutions. Built over 10 years and tested at scale, our technology adapts to the needs of your organisation.
Why world-leading pharma companies rely on Airfinity
Airfinity's solutions are built to speed up and improve decision-making in dynamic markets.
Predictive Power
Airfinity is purely focused on predictive analytics for life sciences. We track early indicators across hundreds of data signals and connect the dots through proprietary models to understand what comes next. Our forecasts consistently outperform other approaches in accuracy and timeliness.
Trusted Partner
Our platform is powered not just by data science and technology, but by world-class disease experts who rigorously validate and contextualise every insight. The result is decision-ready intelligence that leaders can trust when the stakes are highest.
Speed
Our infrastructure continuously monitors and pulls updates from hundreds of global data sources, ensuring new signals are captured as they emerge. With near real-time intelligence, we help our clients stay ahead and operate at speed.
Therapy areas
Life science and health is not one market, but hundreds of different ones. We go deep indication per indication and employ analyst teams of disease specialists.
Powered by over one billion data points Airfinity has developed the market-leading solution for infectious disease intelligence and forecasting, delivering real-time insight across 160+ diseases. Our approach delivered like no other during the COVID-19 pandemic, and since then we have been the go to place for understanding developments in real time and identifying emerging threats in this space.
Airfinity’s Infectious Disease team combines science, EPI, data science and tech to provide solutions that can match any virus.
Powered by structured, predictive data and advanced analytics, Airfinity’s CVRM Intelligence and forecasting platform delivers real-time insight across the cardiometabolic and renal landscape, supporting life science and health system leaders to anticipate demand, optimise resource allocation, and guide clinical and commercial strategy.
Airfinity’s CVRM experts regularly share their leading analysis in this fast-moving market - learn more about how obesity patient demands are shaping the market.
Newsroom and insights
More from Airfinity
Life on the frontline against Ebola
Ebola outbreak becomes DR Congo’s deadliest
Ebola outbreak ‘doubling every 20 days’, warns UN chief
World Cup could cause wave of measles outbreaks across the globe, experts warn
Obesity’s Next Billion Doses: New patient demands, more differentiated treatments and increased access complexity
Is the world ready for a bird flu pandemic? Airfinity assesses global vaccine stockpiles and preparedness
A New Era in Immunisation: Forecasting the Future of Combination Respiratory Vaccines
Airfinity Wins Bloomberg Top 25 UK Startups to Watch
What other conditions could weight-loss drugs treat?
Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels
The West should be on a war footing for the next pandemic
View All →